Ran Salomon

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Metabolic Syndrome

Replacement Therapy

Dendritic Cells

Immune Response

Top Venues

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science immunology 8 (81) (2023)
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science immunology 8 (81) (2023)
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science immunology 8 (81) (2023)
Noy Cohen Saban, Adam Yalin, Tomer Landsberger, Ran Salomon, Ajjai Alva, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science immunology 8 (81) (2023)
Ran Salomon, Hagar Rotem, Yonatan Katzenelenbogen, Assaf Weiner, Noy Cohen Saban, Tali Feferman, Bjørt K Kragesteen, Rony Dahan
Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting. Nature cancer 3 (3) (2022)